Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00063830
Status:
COMPLETED
Last Update Posted:
2022-12-05
First Post:
2003-07-07
Brief Title:
ISIS 2302-CS27 A 6-Week Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen ISIS 2302 in Patients With Mild to Moderate Active Ulcerative Colitis
Sponsor:
Organization:
Ionis Pharmaceuticals Inc
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
None
Enrollment Type:
None
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: